GRP
NBIX icon

Global Retirement Partners’s Neurocrine Biosciences NBIX Stock Holding History

Global Retirement Partners’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.72M Buy
+10,222
New +$1.52M 0.03% 546
2025
Q4 		$341K Buy
2,407
+2,231
+1,268% +$323K 0.01% 1167
2025
Q3 		$24.7K Buy
176
+30
+21% +$4.07K ﹤0.01% 2294
2025
Q2 		$18.4K Buy
+146
New +$16.7K ﹤0.01% 2335
2024
Q4 		$18K Sell
132
-7
-5% -$866 ﹤0.01% 2143
2024
Q3 		$16K Sell
139
-13
-9% -$1.78K ﹤0.01% 2101
2024
Q2 		$20.9K Sell
152
-40
-21% -$5.49K ﹤0.01% 1960
2024
Q1 		$26.5K Buy
192
+8
+4% +$1.09K ﹤0.01% 1689
2023
Q4 		$24.4K Sell
184
-87
-32% -$10K ﹤0.01% 1663
2023
Q3 		$30K Buy
271
+13
+5% +$1.37K ﹤0.01% 1493
2023
Q2 		$24.3K Buy
258
+147
+132% +$14.4K ﹤0.01% 1592
2023
Q1 		$10.9K Buy
111
+5
+5% +$520 ﹤0.01% 1889
2022
Q4 		$12.7K Sell
106
-5
-5% -$586 ﹤0.01% 1688
2022
Q3 		$13K Buy
111
+103
+1,288% +$10.5K ﹤0.01% 1581
2022
Q2 		$1K Hold
8
– – ﹤0.01% 2489
2022
Q1 		$1K Buy
+8
New +$678 ﹤0.01% 2456
2021
Q1 		– Sell
-19
Closed -$2K – 1854
2020
Q4 		$2K Buy
+19
New +$1.83K ﹤0.01% 1617

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Global Retirement Partners's NBIX Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Neurocrine Biosciences (NBIX) in Q2 2026: 10,222 shares worth $1.72M. The stake represents 0.03% of the portfolio and ranks #546 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in NBIX as recently as Q4 2025.

Global Retirement Partners first reported a position in NBIX in Q4 2020 and has held it in 17 quarters since. 777 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Global Retirement Partners held 10,222 shares of Neurocrine Biosciences worth $1.72M as of Q2 2026.
  • Neurocrine Biosciences was a new Global Retirement Partners position in Q2 2026.
  • Neurocrine Biosciences made up 0.03% of Global Retirement Partners's portfolio in Q2 2026, its #546 holding.
  • Global Retirement Partners first reported a position in Neurocrine Biosciences in Q4 2020 and has held it in 17 quarters since.
  • 777 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.